Research ExplorerScientific StaffGuido Sauter Publications

Prof.Dr.Med. ID: 42745

Guido Sauter

graph of relations
Affiliations
151 - 200 out of 506Page size: 50

Publications

  1. 2019

  2. Expression of the immune checkpoint receptor TIGIT in seminoma

    Hinsch, A., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S. & Wilczak, W., 08.2019, In: ONCOL LETT. 18, 2, p. 1497-1502 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

    Büscheck, F., Zub, M., Heumann, A., Hube-Magg, C., Simon, R., Lang, D. S., Höflmayer, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Sauter, G., Huland, H., Graefen, M., Haese, A., Heinzer, H., Schlomm, T., Clauditz, T. S., Burandt, E., Wilczak, W., Steurer, S. & Minner, S., 07.2019, In: TUMOR BIOL. 41, 7, p. 1010428318824815

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Current Therapies of Wilms Tumors in the Adult: Diagnostic Considerations and Treatment Challenges

    Bradtke, M., Rink, M., Büscheck, F., Sauter, G., Dahlem, R., Fisch, M. & Vetterlein, M. W., 06.2019, In: CLIN GENITOURIN CANC. 17, 3, p. e522-e525

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. SNW1 is a prognostic biomarker in prostate cancer

    Höflmayer, D., Willich, C., Hube-Magg, C., Simon, R., Lang, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Huland, H., Graefen, M., Haese, A., Heinzer, H., Minner, S., Büscheck, F., Sauter, G., Schlomm, T., Steurer, S., Clauditz, T. S., Burandt, E., Wilczak, W. & Bernreuther, C., 01.05.2019, In: DIAGN PATHOL. 14, 1, p. 33

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

    Luebke, A. M., Attarchi-Tehrani, A., Meiners, J., Hube-Magg, C., Lang, D. S., Kluth, M., Tsourlakis, M. C., Minner, S., Simon, R., Sauter, G., Büscheck, F., Jacobsen, F., Hinsch, A., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Clauditz, T. S., Burandt, E., Wilczak, W. & Höflmayer, D., 05.2019, In: CANCER BIOL MED. 16, 2, p. 319-330 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. p53 overexpression is a prognosticator of poor outcome in esophageal cancer

    Melling, N., Norrenbrock, S., Kluth, M., Simon, R., Hube-Magg, C., Steurer, S., Hinsch, A., Burandt, E., Jacobsen, F., Wilczak, W., Quaas, A., Bockhorn, M., Grupp, K., Tachezy, M., Izbicki, J., Sauter, G. & Gebauer, F., 04.2019, In: ONCOL LETT. 17, 4, p. 3826-3834 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance

    Horak, P., Weischenfeldt, J., von Amsberg, G., Beyer, B., Schütte, A., Uhrig, S., Gieldon, L., Klink, B., Feuerbach, L., Hübschmann, D., Kreutzfeldt, S., Heining, C., Maier, S., Hutter, B., Penzel, R., Schlesner, M., Eils, R., Sauter, G., Stenzinger, A., Brors, B., Schröck, E., Glimm, H., Fröhling, S. & Schlomm, T., 04.2019, In: CSH MOL CASE STUD. 5, 2

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

    Schroeder, C., Grell, J., Hube-Magg, C., Kluth, M., Lang, D., Simon, R., Höflmayer, D., Minner, S., Burandt, E., Clauditz, T. S., Büscheck, F., Jacobsen, F., Huland, H., Graefen, M., Schlomm, T., Sauter, G. & Steurer, S., 01.03.2019, In: BMC CANCER. 19, 1, p. 193

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

    Eichenauer, T., Hussein, M., Hube-Magg, C., Kluth, M., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Steurer, S., Clauditz, T. S., Luebke, A. M., Burandt, E., Wilczak, W., Hinsch, A., Dum, D., Beyer, B., Steuber, T., Huland, H., Graefen, M., Simon, R., Sauter, G., Melling, N., Schlomm, T. & Minner, S., 01.03.2019, In: ONCOTARGET. 10, 18, p. 1729-1744 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

    Press, M. F., Seoane, J. A., Curtis, C., Quinaux, E., Guzman, R., Sauter, G., Eiermann, W., Mackey, J. R., Robert, N., Pienkowski, T., Crown, J., Martin, M., Valero, V., Bee, V., Ma, Y., Villalobos, I. & Slamon, D. J., 01.03.2019, In: JAMA ONCOL. 5, 3, p. 366-375 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer

    Kemper, M., Strohm, T., Grupp, K., Ghadban, T., Bogoevski, D., Bachmann, K., Bockhorn, M., Sauter, G., Izbicki, J. R. & Reeh, M., 03.2019, In: ANTICANCER RES. 39, 3, p. 1191-1196 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy

    Marks, P., Gild, P., Soave, A., Janisch, F., Minner, S., Engel, O., Vetterlein, M. W., Shariat, S. F., Sauter, G., Dahlem, R., Fisch, M. & Rink, M., 03.2019, In: SURG ONCOL. 28, p. 208-213 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

    Minner, S., Lutz, J., Hube-Magg, C., Kluth, M., Simon, R., Höflmayer, D., Burandt, E., Tsourlakis, M. C., Sauter, G., Büscheck, F., Wilczak, W., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Jacobsen, F., Hinsch, A., Poos, A., Oswald, M., Rippe, K., König, R. & Schroeder, C., 02.2019, In: PROSTATE. 79, 3, p. 302-311 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes

    Münscher, A., Prochnow, S., Gulati, A., Sauter, G., Lörincz, B., Blessmann, M., Hanken, H., Böttcher, A. & Clauditz, T. S., 01.2019, In: CLIN ORAL INVEST. 23, 1, p. 361-367 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

    Mandelkow, T., Blessin, N. C., Lueerss, E., Pott, L., Simon, R., Li, W., Wellge, B., Debatin, N. F., Höflmayer, D., Izbicki, J. R., Büscheck, F., Luebke, A. M., Wittmer, C., Jacobsen, F., Lutz, F., Burandt, E., Steurer, S., Sauter, G., Tsourlakis, M. C., Wilczak, W., Hinsch, A. & Minner, S., 2019, In: DIS MARKERS. 2019, p. 2532518

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

    Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E-C., Steurer, S., Wilczak, W. & Hinsch, A., 2019, In: DIS MARKERS. 2019, p. 5160565

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

    Kind, S., Merenkow, C., Büscheck, F., Möller, K., Dum, D., Chirico, V., Luebke, A. M., Höflmayer, D., Hinsch, A., Jacobsen, F., Göbel, C., Weidemann, S., Fraune, C., Möller-Koop, C., Hube-Magg, C., Clauditz, T. S., Simon, R., Sauter, G., Wilczak, W., Bawahab, A. A., Izbicki, J. R., Perez, D. & Marx, A., 2019, In: DIS MARKERS. 2019, 4928315.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2018

  20. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories

    Gerhauser, C., Favero, F., Risch, T., Simon, R., Feuerbach, L., Assenov, Y., Heckmann, D., Sidiropoulos, N., Waszak, S. M., Hübschmann, D., Urbanucci, A., Girma, E. G., Kuryshev, V., Klimczak, L. J., Saini, N., Stütz, A. M., Weichenhan, D., Böttcher, L-M., Toth, R., Hendriksen, J. D., Koop, C., Lutsik, P., Matzk, S., Warnatz, H-J., Amstislavskiy, V., Feuerstein, C., Raeder, B., Bogatyrova, O., Schmitz, E-M., Hube-Magg, C., Kluth, M., Huland, H., Graefen, M., Lawerenz, C., Henry, G. H., Yamaguchi, T. N., Malewska, A., Meiners, J., Schilling, D., Reisinger, E., Eils, R., Schlesner, M., Strand, D. W., Bristow, R. G., Boutros, P. C., von Kalle, C., Gordenin, D., Sültmann, H., Brors, B., Sauter, G., Plass, C., Yaspo, M-L., Korbel, J. O., Schlomm, T. & Weischenfeldt, J., 10.12.2018, In: CANCER CELL. 34, 6, p. 996-1011.e8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

    Li, W., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Pott, L., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S., Wilczak, W. & Hinsch, A., 04.12.2018, In: BMC CANCER. 18, 1, p. 1209

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

    Büscheck, F., Fraune, C., Simon, R., Kluth, M., Hube-Magg, C., Möller-Koop, C., Shadanpour, N., Bannenberg, C., Eichelberg, C., Höflmayer, D., Clauditz, T., Wittmer, C., Wilczak, W., Sauter, G., Fisch, M., Rink, M. & Eichenauer, T., 12.2018, In: UROL ONCOL-SEMIN ORI. 36, 12, p. 531.e19-531.e25

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Deep Learning for Natural Language Processing in Urology: State-of-the-Art Automated Extraction of Detailed Pathologic Prostate Cancer Data From Narratively Written Electronic Health Records

    Leyh-Bannurah, S-R., Tian, Z., Karakiewicz, P. I., Wolffgang, U., Sauter, G., Fisch, M., Pehrke, D., Huland, H., Graefen, M. & Budäus, L., 12.2018, In: JCO CLIN CANCER INFO. 2, p. 1-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. High expression of class III β-tubulin in upper gastrointestinal cancer types

    Höflmayer, D., Öztürk, E., Schroeder, C., Hube-Magg, C., Blessin, N. C., Simon, R., Lang, D. S., Neubauer, E., Göbel, C., Heinrich, M-C., Fraune, C., Möller, K., Armbrust, M., Freytag, M., Hinsch, A., Lühr, C., Noack, M., Reiswich, V., Weidemann, S., Bockhorn, M., Perez, D., Izbicki, J. R., Sauter, G. & Jacobsen, F., 12.2018, In: ONCOL LETT. 16, 6, p. 7139-7145 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib

    Berger, L-A., Janning, M., Velthaus, J-L., Ben-Batalla, I., Schatz, S., Falk, M., Iglauer, P., Simon, R., Cao, R., Forcato, C., Manaresi, N., Bramlett, K., Buson, G., Hanssen, A., Tiemann, M., Sauter, G., Bokemeyer, C., Riethdorf, S., Reck, M., Pantel, K., Wikman, H. & Loges, S., 12.2018, In: J THORAC ONCOL. 13, 12, p. e243-e246

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

    Grupp, K., Hofmann, B., Kutup, A., Bachmann, K., Bogoevski, D., Melling, N., Uzunoglu, F. G., El Gammal, A. T., Koop, C., Simon, R., Steurer, S., Krech, T., Burdak-Rothkamm, S., Jacobsen, F., Sauter, G., Izbicki, J. & Wilczak, W., 12.11.2018, In: BMC CANCER. 18, 1, p. 1106

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

    Wang, Y., Xu, X., Maglic, D., Dill, M. T., Mojumdar, K., Ng, P. K-S., Jeong, K. J., Tsang, Y. H., Moreno, D., Bhavana, V. H., Peng, X., Ge, Z., Chen, H., Li, J., Chen, Z., Zhang, H., Han, L., Du, D., Creighton, C. J., Mills, G. B., Camargo, F., Liang, H. & Cancer Genome Atlas Research Network, 30.10.2018, In: CELL REP. 25, 5, p. 1304-1317.e5

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

    Korkut, A., Zaidi, S., Kanchi, R. S., Rao, S., Gough, N. R., Schultz, A., Li, X., Lorenzi, P. L., Berger, A. C., Robertson, G., Kwong, L. N., Datto, M., Roszik, J., Ling, S., Ravikumar, V., Manyam, G., Rao, A., Shelley, S., Liu, Y., Ju, Z., Hansel, D., de Velasco, G., Pennathur, A., Andersen, J. B., O'Rourke, C. J., Ohshiro, K., Jogunoori, W., Nguyen, B-N., Li, S., Osmanbeyoglu, H. U., Ajani, J. A., Mani, S. A., Houseman, A., Wiznerowicz, M., Chen, J., Gu, S., Ma, W., Zhang, J., Tong, P., Cherniack, A. D., Deng, C., Resar, L., Weinstein, J. N., Mishra, L., Akbani, R. & Cancer Genome Atlas Research Network, 24.10.2018, In: CELL SYST. 7, 4, p. 422-437.e7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer

    Kluth, M., Scherzai, S., Büschek, F., Fraune, C., Möller, K., Höflmayer, D., Minner, S., Göbel, C., Möller-Koop, C., Hinsch, A., Neubauer, E., Tsourlakis, M. C., Sauter, G., Heinzer, H., Graefen, M., Wilczak, W., Luebke, A. M., Burandt, E., Steurer, S., Schlomm, T. & Simon, R., 10.2018, In: GENE CHROMOSOME CANC. 57, 10, p. 504-512 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Evaluating Guideline Adherence for T1 Bladder Cancer Treatment and Surveillance: A Retrospective German Multicenter Observation

    Vetterlein, M. W., Gild, P., Marks, P., Roschinski, J., Doh, O., Höppner, W., Wagner, W., Isbarn, H., Büscheck, F., Sauter, G., Dahlem, R., Soave, A., Fisch, M. & Rink, M., 10.2018, In: UROL INT. 101, 3, p. 285-292 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

    Wilczak, W., Wittmer, C., Clauditz, T., Minner, S., Steurer, S., Büscheck, F., Krech, T., Lennartz, M., Harms, L., Leleu, D., Ahrens, M., Ingwerth, S., Günther, C. T., Koop, C., Simon, R., Jacobsen, F., Tsourlakis, M. C., Chirico, V., Höflmayer, D., Vettorazzi, E., Haese, A., Steuber, T., Salomon, G., Michl, U., Budäus, L., Tilki, D., Thederan, I., Fraune, C., Göbel, C., Henrich, M-C., Juhnke, M., Möller, K., Bawahab, A. A., Uhlig, R., Adam, M., Weidemann, S., Beyer, B., Huland, H., Graefen, M., Sauter, G. & Schlomm, T., 09.2018, In: EUR UROL. 74, 3, p. 376-386 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    Heumann, A., Kaya, Ö., Burdelski, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Beyer, B., Thederan, I., Sauter, G., Izbicki, J. R., Luebke, A. M., Hinsch, A., Jacobsen, F., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Schlomm, T. & Wilczak, W., 21.08.2018, In: SCI REP-UK. 8, 1, p. 12821

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  33. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

    Kahles, A., Lehmann, K-V., Toussaint, N. C., Hüser, M., Stark, S. G., Sachsenberg, T., Stegle, O., Kohlbacher, O., Sander, C., Rätsch, G. & Cancer Genome Atlas Research Network, 13.08.2018, In: CANCER CELL. 34, 2, p. 211-224.e6

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Comprehensive Characterization of Cancer Driver Genes and Mutations

    Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., Kwok-Shing Ng, P., Jeong, K. J., Cao, S., Wang, Z., Gao, J., Gao, Q., Wang, F., Liu, E. M., Mularoni, L., Rubio-Perez, C., Nagarajan, N., Cortés-Ciriano, I., Zhou, D. C., Liang, W-W., Hess, J. M., Yellapantula, V. D., Tamborero, D., Gonzalez-Perez, A., Suphavilai, C., Ko, J. Y., Khurana, E., Park, P. J., Van Allen, E. M., Liang, H., Lawrence, M. S., Godzik, A., Lopez-Bigas, N., Stuart, J., Wheeler, D., Getz, G., Chen, K., Lazar, A. J., Mills, G. B., Karchin, R., Ding, L. & MC3 Working Group, 09.08.2018, In: CELL. 174, 4, p. 1034-1035 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer

    Neubauer, E., Latif, M., Krause, J., Heumann, A., Armbrust, M., Luehr, C., Fraune, C., Hube-Magg, C., Kluth, M., Möller-Koop, C., Sauter, G., Simon, R., Beyer, B., Pompe, R. S., Thederan, I., Schlomm, T. & Büscheck, F., 08.2018, In: EXP MOL PATHOL. 105, 1, p. 50-56 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

    Ricketts, C. J., De Cubas, A. A., Fan, H., Smith, C. C., Lang, M., Reznik, E., Bowlby, R., Gibb, E. A., Akbani, R., Beroukhim, R., Bottaro, D. P., Choueiri, T. K., Gibbs, R. A., Godwin, A. K., Haake, S., Hakimi, A. A., Henske, E. P., Hsieh, J. J., Ho, T. H., Kanchi, R. S., Krishnan, B., Kwiatkowski, D. J., Lui, W., Merino, M. J., Mills, G. B., Myers, J., Nickerson, M. L., Reuter, V. E., Schmidt, L. S., Shelley, C. S., Shen, H., Shuch, B., Signoretti, S., Srinivasan, R., Tamboli, P., Thomas, G., Vincent, B. G., Vocke, C. D., Wheeler, D. A., Yang, L., Kim, W. Y., Robertson, A. G., Spellman, P. T., Rathmell, W. K., Linehan, W. M. & Cancer Genome Atlas Research Network, 19.06.2018, In: CELL REP. 23, 12, p. 3698

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target

    Drenckhan, A., Freytag, M., Supuran, C. T., Sauter, G., Izbicki, J. R. & Gros, S. J., 06.2018, In: J ENZYM INHIB MED CH. 33, 1, p. 1024-1033 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Immunohistochemically detected IDH1 mutation is rare and mostly heterogeneous in prostate cancer

    Hinsch, A., Brolund, M., Hube-Magg, C., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Steurer, S., Luebke, A., Angerer, A., Wittmer, C., Neubauer, E., Göbel, C., Büscheck, F., Minner, S., Wilczak, W., Schlomm, T., Jacobsen, F., Clauditz, T. S., Krech, T., Tsourlakis, M. C. & Schroeder, C., 06.2018, In: WORLD J UROL. 36, 6, p. 877-882 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer

    Heinrich, M-C., Göbel, C., Kluth, M., Bernreuther, C., Sauer, C., Schroeder, C., Möller-Koop, C., Hube-Magg, C., Lebok, P., Burandt, E., Sauter, G., Simon, R., Huland, H., Graefen, M., Heinzer, H., Schlomm, T. & Heumann, A., 31.05.2018, In: BMC CANCER. 18, 1, p. 612

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Sauter, G., Clauditz, T., Steurer, S., Wittmer, C., Büscheck, F., Krech, T., Lutz, F., Lennartz, M., Harms, L., Lawrenz, L., Möller-Koop, C., Simon, R., Jacobsen, F., Wilczak, W., Minner, S., Tsourlakis, M. C., Chirico, V., Weidemann, S., Haese, A., Steuber, T., Salomon, G., Matiu, M., Vettorazzi, E., Michl, U., Budäus, L., Tilki, D., Thederan, I., Pehrke, D., Beyer, B., Fraune, C., Göbel, C., Heinrich, M., Juhnke, M., Möller, K., Bawahab, A. A. A., Uhlig, R., Huland, H., Heinzer, H., Graefen, M. & Schlomm, T., 05.2018, In: EUR UROL. 73, 5, p. 674-683 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. EZH2 overexpression in head and neck cancer is related to lymph node metastasis

    Nienstedt, J. C., Schroeder, C., Clauditz, T., Simon, R., Sauter, G., Muenscher, A., Blessmann, M., Hanken, H. & Pflug, C., 03.2018, In: J ORAL PATHOL MED. 47, 3, p. 240-245 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

    Heumann, A., Heinemann, N., Hube-Magg, C., Lang, D. S., Grupp, K., Kluth, M., Minner, S., Möller-Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wilczak, W., Wittmer, C., Jacobsen, F., Huland, H., Simon, R., Schlomm, T., Sauter, G., Steurer, S., Lebok, P. & Hinsch, A., 05.01.2018, In: BMC CANCER. 18, 1, p. 37

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor Features: A tissue microarray study on 8,877 human cancers and normal tissues

    Burdelski, C., Jakani-Karimi, N., Jacobsen, F., Möller-Koop, C., Minner, S., Simon, R., Sauter, G., Steurer, S., Clauditz, T. S. & Wilczak, W., 01.2018, In: ONCOL REP. 39, 1, p. 3-12 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck

    Clauditz, T. S., Böttcher, A., Hanken, H., Borgmann, K., Sauter, G., Wilczak, W., Grob, T. & Münscher, A., 01.2018, In: J CANCER RES CLIN. 144, 1, p. 53-61 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

    Kluth, M., Volta, H., Hussein, M., Taskin, B., Frogh, S., Möller-Koop, C., Büscheck, F., Jacobsen, F., Tsourlakis, M. C., Lübke, A. M., Hinsch, A., Clauditz, T., Graefen, M., Heinzer, H., Huland, H., Minner, S., Sauter, G., Wilczak, W., Schlomm, T. & Simon, R., 2018, In: CANCER MANAG RES. 10, p. 5909-5917 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Upregulation of centromere protein F is linked to aggressive prostate cancers

    Göbel, C., Özden, C., Schroeder, C., Hube-Magg, C., Kluth, M., Möller-Koop, C., Neubauer, E., Hinsch, A., Jacobsen, F., Simon, R., Sauter, G., Michl, U., Pehrke, D., Huland, H., Graefen, M., Schlomm, T. & Luebke, A. M., 2018, In: CANCER MANAG RES. 10, p. 5491-5504 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. 2017

  48. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

    Tsourlakis, M. C., Eleftheriadou, A., Stender, A., Weigand, P., Grupp, K., Hube-Magg, C., Kluth, M., Schroeder, C., Steurer, S., Hinsch, A., Luebke, A., Angerer, A., Wittmer, C., Friedrich, E., Göbel, C., Büscheck, F., Heinzer, H., Graefen, M., Simon, R., Sauter, G., Wilczak, W., Minner, S., Schlomm, T. & Jacobsen, F., 07.12.2017, In: CARCINOGENESIS. 38, 12, p. 1180-1187 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder

    Vetterlein, M. W., Roschinski, J., Gild, P., Marks, P., Soave, A., Doh, O., Isbarn, H., Höppner, W., Wagner, W., Shariat, S. F., Brausi, M., Büscheck, F., Sauter, G., Fisch, M. & Rink, M., 12.2017, In: TRANSL ANDROL UROL. 6, 6, p. 1018-1026 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer

    Burdelski, C., Shihada, R., Hinsch, A., Angerer, A., Göbel, C., Friedrich, E., Hube-Magg, C., Burdak-Rothkamm, S., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Büscheck, F., Wittmer, C., Clauditz, T. S., Krech, T., Tsourlakis, M. C., Minner, S., Graefen, M., Schlomm, T., Wilczak, W. & Jacobsen, F., 11.2017, In: PROSTATE. 77, 15, p. 1528-1538 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome

    Nienstedt, J. C., Gröbe, A., Clauditz, T., Simon, R., Muenscher, A., Knecht, R., Sauter, G., Moebius, C., Blessmann, M., Heiland, M. & Pflug, C., 11.2017, In: J ORAL PATHOL MED. 46, 10, p. 986-990

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study

    Weixler, B., Viehl, C. T., Warschkow, R., Guller, U., Ramser, M., Sauter, G. & Zuber, M., 01.10.2017, In: JAMA SURG. 152, 10, p. 912-920 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas

    Göppel, J., Möckelmann, N., Münscher, A., Sauter, G. & Schumacher, U., 10.2017, In: ANTICANCER RES. 37, 10, p. 5435-5440 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next